Expression of the ␣5␤1 fibronectin (Fn) integrin is well recognized in the corneal epithelium and has been postulated to increase during wound healing. In the present study, the regulatory influence of the positive transcription factors Sp1/Sp3 on the activity directed by the promoter of the ␣5 gene was examined in rabbit corneal epithelial cells (RCECs) primary cultured at various cell densities. METHODS. Expression of the ␣5 subunit was assessed at the transcriptional level by semiquantitative RT-PCR analyses. The regulatory elements necessary to direct expression of the ␣5 gene were identified by transfecting RCECs with recombinant plasmids bearing various lengths from the ␣5 gene promoter fused to the CAT reporter gene. Binding of Sp1/Sp3 to the ␣5 promoter was assessed by both electrophoretic mobility shift assays (EMSAs) and DNaseI footprinting. Endogenous levels of Sp1/Sp3 were determined by Western blot and supershift analyses. The regulatory influence exerted by Sp1/Sp3 on the ␣5 promoter was evaluated both by site-directed mutagenesis and cotransfection in Sp1-deficient Drosophila SL-2 Schneider cells. RESULTS. Subconfluent RCECs expressed nearly five times more ␣5 transcript than 48-hour postconfluent RCECs. The activity directed by the ␣5 promoter was found to be affected by cell density. Strong promoter activity was observed in subconfluent RCECs, whereas a dramatic repression was measured in postconfluent cells. EMSA and DNaseI footprinting provided evidence for the binding of Sp1 to both a proximal site located within the previously reported ␣5 fibronectin responsive element (FRE), and a distal site located between positions Ϫ117 and Ϫ101. Cotransfection experiments in Schneider cells, as well as transfection of RCECs with recombinant constructs bearing mutations into the distal Sp1 site, confirmed the positive regulatory influence of Sp1 on both the Ϫ42/Ϫ92 and Ϫ92/Ϫ132 ␣5 promoter segments. Most of all, EMSA and Western blot analyses demonstrated the expression of substantial amounts of Sp1/Sp3 in subconfluent but not postconfluent RCECs. CONCLUSIONS. These results provide support to the hypothesis that the strong reduction in the activity of the ␣5 promoter when RCECs reach a high cell density is the consequence of a reduced expression of Sp1/Sp3 under such cell culture conditions. (Invest Ophthalmol Vis Sci. 2003;44:3742-3755) DOI:10.1167/iovs.03-0191 I nside-out signaling between the extracellular matrix (ECM) and the cell is essentially mediated by a family of cell surface glycoproteins named integrins.
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1,2 These transmembrane receptors are known to play major functions in many physiological and pathologic processes, including embryonic development, inflammation, metastasis, and wound healing. 3 All members of the integrin superfamily are constituted of noncovalently associated ␣ and ␤ subunits. [1] [2] [3] [4] Both subunits contain a large extracellular domain, a transmembrane region, and a short cytoplasmic C-terminal tail that interacts with cytoskeletal components, such as ␣-actinin, vinculin, talin, tensin, and paxilin. 3, [5] [6] [7] [8] In a recent survey of the human genome, 24 ␣ and 9 ␤ integrin subunits were identified, 9 which implies 6 novel ␣-subunits and 1 novel ␤-subunit in addition to the previously recognized 18 ␣-and 8 ␤-subunits reported to form 24 different heterodimers. 1, 3, 7, 10 However, the existence of these new integrin subunits remains to be firmly established.
Because of its anterior location in the eye, the cornea, and more specifically its epithelium, are continuously exposed to a large variety of injuries, including physiological and mechanical stresses. It is now well established that such types of corneal epithelial injuries in turn activate wound healing, a phenomenon that is influenced by growth factors and ECM components (for reviews, see . Many integrins have been identified in the corneal epithelium. These include ␣-subunit-2, -3, -4, -5, -6, -V, and -9, and ␤-subunit-1, -4, and -5. [15] [16] [17] [18] [19] [20] [21] Soon after a wound is inflicted on the corneal epithelium, the basal cells that border the injured area and stromal keratocytes start producing massive amounts of fibronectin (Fn). 22, 23 Fn promotes corneal cell migration, both in vitro 24 and in vivo, 25 by acting as a temporary matrix to which corneal epithelial cells attach as they migrate over the wounded area. 26 Results from a few studies point toward an Fn-mediated increase in expression of the main Fn-binding integrin ␣5␤1 during corneal wound healing. 16, 27 Expression of the ␣5 subunit may therefore make a substantial contribution to wound healing by promoting cell adhesion and migration during this process.
Because integrins from the ␤1 family are known to play major functions in the regulation of cell proliferation, differentiation, and migration, their expression may therefore be closely related to the state of cell growth. Fingerman and Hemler 28 have observed that when normal human fibroblasts reach quiescence, expression of both the ␣2 and ␣3 integrin subunits, but not that of ␤1, is reduced. Similar results have been reported in other studies for the ␣5-subunit, in addition to the ␣2 and ␣3 integrin subunits. 29, 30 These observations all suggest that cell-to-cell contact probably controls the level to which ␣ integrin subunits are expressed at both the mRNA and protein levels in vitro.
In the present study, we demonstrate that expression of the gene encoding the ␣5 integrin subunit is dramatically altered in a manner that depends on the cell density reached in primary cultured RCECs. The increased promoter function observed when transfections were conducted in subconfluent RCECs was determined by both the previously described fibronectin responsive element (FRE) identified between ␣5 sequences Ϫ82 to Ϫ56, 31 and a short GC-rich segment from the ␣5 promoter extending between positions Ϫ92 and Ϫ132. Most of all, we provide evidence that the positive influence exerted by both of these ␣5 promoter segments is primarily mediated through their recognition by the positive transcription factors Sp1/Sp3, two proteins that belong to a family of GC-rich binding transcription factors, the Sp family, that includes three other proteins-Sp3, Sp4, and Sp5 [32] [33] [34] [35] [36] -and which are expressed in primary cultured RCECs. 31, 37 We demonstrate that the strong reduction in the ␣5 promoter function when RCECs reach postconfluence is the consequence of a dramatic reduction in the expression of both Sp1 and Sp3 when these cells are maintained at a high cell density.
MATERIALS AND METHODS

Plasmids and Oligonucleotides
The plasmids Ϫ954␣5CAT, Ϫ178␣5CAT, Ϫ132␣5CAT, Ϫ92␣5CAT, and Ϫ42␣5CAT, which bear the chloramphenicol acetyl transferase (CAT) reporter gene fused to DNA fragments from the human ␣5 gene upstream regulatory sequence extending up to 5Ј positions Ϫ954, Ϫ178, Ϫ132, Ϫ92, and Ϫ42, respectively, all sharing a common 3Ј end located at position ϩ23, have been previously described. 37 The Ϫ132␣5CAT plasmids bearing mutations into either the proximal (Ϫ132␣5Mp) or the distal (Ϫ132␣5Md) Sp1 sites, or both (Ϫ132␣5Mpϩd) were constructed through site-directed mutagenesis (QuikChange Site-Directed Mutagenesis kit; Stratagene, La Jolla, CA), using the following mutated oligonucleotides: Sp1Mp top strand, 5Ј-GCCGGGAGTTTGGCAAACTAAAAAACGCG-TTGAGTCATTCGCCTC-TGGGAGG-3Ј; Sp1Mp bottom strand, 5Ј-CCTCCCAGAGGCGAATGAC-TCAACGCGTTTTTTAGTTTGCCAAACTCCCGGC-3Ј; Sp1Md top strand, 5Ј-CCCAGGAATGCCCCCCAAACAGCCAAATCGGCAGGCGGGGGGA-GG-3Ј; Sp1Md bottom strand, 5Ј-CCTCCCCCCGCCTGCCGATTTGGCT-GTTTGGGGGGCATTCCTGGG-3Ј (mutated residues are in bold). The Sp1 and Sp3 expression plasmids pPacSp1 and pPacSp3, respectively, which allow for a high level of expression of these proteins in Drosophila Schneider cells were obtained from Guntram Suske (Institute for Molecular Biology and Tumor Research, Marburg, Germany), and the mammalian Sp1 expression plasmid pSiSp1 was provided by Winnie Eskild (Department of Biochemistry, University of Oslo, Oslo, Norway). The LacZ expression plasmid pAC5/V5-His/LacZ was obtained from Invitrogen (Carlsbad, CA).
The double-stranded oligonucleotides used in the present study were chemically synthesized with a commercial apparatus (Biosearch 8700; Millipore, Bedford, MA). They contained the human ␣5 promoter comprising positions Ϫ143 to Ϫ86 and designated ␣5.1 (5Ј-GTTTCCAGGGACCCAGGAATGCCCCCCCGCCAGCCCCCTCGGCAG-GCGGGGGGAGGGC-3Ј), or shorter derivatives that extend from position Ϫ143 to Ϫ106 (␣5.2: 5Ј-GTTTCCAGGGACCCAGGAATGC-CCCCCCGCCAGCCCCC-3Ј) and Ϫ105 to Ϫ86 (␣5.3: 5Ј-TCGGCAG-GCGGGGG-GAGGGC-3Ј), the sequence of the ␣5 FRE (5Ј-GATCAGC-CGGGAGTTTGGCAAACTCCTCCCC-3Ј), 31 the DNA binding site for human HeLa CTF/NF-I in adenovirus type 2 (Ad2; 5Ј-GATCTTATTTT-GGATTGAAGCCAATATGAG-3Ј), 38 and the high-affinity binding site for Sp1 (5Ј-GATCATATCTGCGGGGCGGGGCAGACACAG-3Ј).
39
Cell Culture
RCECs were obtained from freshly dissected rabbit corneas and cultured in 60-mm plates as described, 40 except for the following modifications: corneas were removed within 90 minutes of death from pathogen-free albino rabbits weighing 2 to 3 kg and obtained from a local abattoir. They were rinsed twice for 6-minutes each in Hanks' balanced salt solution (HBSS) containing 50 g/mL gentamicin sulfate and a 1:100 dilution of an antibiotic mixture (5 mg/mL penicillin G in salt solution, 5 mg/mL streptomycin sulfate, and 10 mg/mL neomycin sulfate) before treatment with dispase II (2 mg/mL in calcium-and magnesium-free HBSS) for 20 minutes at 37°C. The corneal epithelia were then transferred into 25-cm 2 tissue-culture flasks (each flask contained the epithelia of three rabbit corneas) and grown in supplemental hormonal epithelial medium (SHEM) for 8 days.
40 Trypsin (0.05% trypsin, 0.5 mM EDTA) 2 mL/25 cm 2 was then added for 5 minutes and the RCECs harvested, counted, and seeded into six-well tissue culture plates. Cells were then grown either to subconfluence (5 ϫ 10 4 cells/cm 2 cultured for 48 hours; this condition yielded near 70% coverage) or to postconfluence (1.5 ϫ 10 6 cells/cm 2 cultured for 48 hours, which yielded 100% coverage). Cells where then maintained for an additional 48 hours in culture in SHEM, as described previously. 41 Gentamicin was added to all media at a final concentration of 15 g/mL. Drosophila Schneider cells (ATCC CRL-1963; American Type Culture Collection, Manassas, VA) were cultured at 28°C without CO 2 in Schneider medium (Sigma-Aldrich, Oakville, Ontario, Canada) supplemented with 10% FBS (Invitrogen-Gibco, Burlington, Ontario, Canada) and 20 g/mL gentamicin. Rat pituitary GH4C1 cells were grown in Ham's F10 medium (Sigma-Aldrich) supplemented with 10% FBS (Invitrogen-Gibco) and 20 g/mL gentamicin, in 5% CO 2 at 37°C.
Transient Transfection and CAT Assay
RCECs were grown either to subconfluence (near 70% coverage) or postconfluence (100% coverage for 48 hours in culture) and transiently transfected by using a polycationic detergent (Lipofectamine; Invitrogen-Gibco), as recommended by the manufacturer. Each transfected plate received 1.0 g of the test plasmid and 0.5 g of the human growth hormone (hGH)-encoding plasmid pXGH5. 42 Under those conditions, subconfluent RCECs were transfected with an efficiency of 48% Ϯ 4%, as revealed by cotransfection of the green fluorescent protein (GFP) expression plasmid pEGFP-C3 (Clontech, Palo Alto, CA) and normalization to Hoechst-stained nuclei, whereas postconfluent cells yielded an efficiency of transfection of 39% Ϯ 7% (data not shown). In the Sp1 overexpression experiments conducted in both postconfluent and subconfluent RCECs, 0.5 g of the Sp1 expression plasmid pSiSp1 was added. Drosophila Schneider cells were transfected according to the calcium phosphate precipitation procedure 43, 44 at a density of 1 ϫ 10 6 cells per 60-mm culture plate. CAT activities from transfected Schneider cells were normalized to the amount of ␤-gal encoded by the plasmid pAC5/V5-His/LacZ and cotransfected along with the CAT recombinant constructs. Each cellcontaining plate therefore received 16 g of the test plasmid, 4 g of pAC5/V5-His/LacZ, and 1 g of pPacSp1, pPacSp3, or both. Levels of CAT activity for all transfected cells were determined as described, 43 normalized to the amount of hGH secreted into the culture media, and assayed with a kit for quantitative measurement of hGH (Immunocorp, Montréal, Québec, Canada). Measurement of ␤-gal activity was performed according to standard procedures. 45 The result presented for each test plasmid transfected corresponds to the mean Ϯ SD of at least three separate transfections performed in triplicate. To be considered significant, each activity level had to be at least three times over the IOVS, September 2003, Vol. 44, No. 9 Regulation of the ␣5 Gene Promoter by Sp1/Sp3 3743 background level caused by the reaction buffer used (usually corresponding to 0.15% chloramphenicol conversion).
Nuclear Extracts and Electrophoretic Mobility Shift Assay
Crude nuclear extracts were prepared from subconfluent (1 ϫ 10 4 cells/cm 2 cultured for 72 hours usually yielded a near 70% coverage of the culture flasks) or 48-hour postconfluent RCECs (3 ϫ 10 4 cells/cm 2 ; under such seeding conditions, cells reach 100% coverage of the culture flasks in 4 days, after which they are maintained for an additional 48 hours before they are removed from the flasks) and dialyzed against DNaseI buffer (50 mM KCl, 4 mM MgCl 2 , 20 mM K 3 PO 4 [pH 7.4], 1 mM ␤-mercaptoethanol, 20% glycerol) as described. 46 Extracts were kept frozen in small aliquots at Ϫ80°C until use. EMSAs were conducted by using either the 58-bp ␣5.1 double-stranded oligonucleotide, which bears the ␣5 promoter sequence from positions Ϫ143 to Ϫ86, or the Sp1 oligomer as 5Ј end-labeled probes. Approximately 3 ϫ . When indicated, molar excesses (as specified in the figure legends) of unlabeled double-stranded oligonucleotides, bearing various DNA segments from the ␣5 promoter (␣5.1, ␣5.2, ␣5.3, an ␣5-FRE) or target sequences for known transcription factors (Sp1 and NF1) were added as unlabeled competitors during the assay. Incubation proceeded at room temperature for 15 minutes, at which time DNA-protein complexes were separated by gel electrophoresis through either 5% or 8% native polyacrylamide gels run against Tris-glycine buffer, as described. 31, 47 Gels were dried and autoradiographed at Ϫ80°C to reveal the position of the shifted DNA-protein complexes generated.
DNase I Footprinting
A 165-bp BamHI/XhoI DNA fragment spanning the ␣5 promoter sequence from position Ϫ132 to ϩ23 was 5Ј end-labeled and used as a probe in DNaseI footprinting. DNase I digestion was performed in DNase I buffer 44 by incubating a 3 ϫ 10 4 -cpm-labeled probe with 10 L of recombinant Sp1 protein (GST-Sp1-8xHis protein; kindly provided by Claude Labrie, Oncology and Molecular Endocrinology Research Center, Hospital Center Laval University (CHUL) Research Center, Québec, Canada) obtained by overexpressing the pGEX-Sp1-8xHis plasmid in Escherichia coli BL21 CodonPlus R1L cells before being purified as described. 48 Further analyses of the digested products on polyacrylamide sequencing gels were performed as described previously. 44 
RT-PCR and Northern Blot mRNA Analyses
Total RNA was isolated from subconfluent and 48-hour postconfluent RCECs, using extraction reagent (TRI; Molecular Research Center, Inc., Cincinnati, OH), and reverse transcribed with a commercial kit (Superscript II Transcriptase; Invitrogen-Gibco). Briefly, 10 g total RNA was incubated in the presence of 10 mM dNTPs, 3 g oligo dT primer, 15 mM DTT, and 1 L RNAse inhibitor (RNAguard; Pharmacia-LKB), in first-strand buffer. Reverse transcriptase was added (2 L of 200 U/L), and incubation proceeded at 37°C for 90 minutes, at which time newly synthesized first-strand cDNAs were column purified (QIAquick nucleotide removal kit; Qiagen, Santa Clarita, CA) and used for PCR amplification of both the human ␣4 and ␣5 integrin subunit transcripts as well as the 18S ribosomal RNA. The DNA sequence of both the 5Ј and 3Ј template primers for both human ␣4 (5Ј primer: nucleotides [nt] 2154-2174; 3Ј primer: nt 2926-2907; 772-bp PCR product) and ␣5 (5Ј primer: nt 3000-3023; 3Ј primer: nt 3170-3147; 171-bp PCR product) were derived from their corresponding human genes (GenBank accession numbers XM039011 and X06256, respectively; http://www.ncbi. nlm.nih.gov/Genbank; provided in the public domain by the National Center for Biotechnology Information, Bethesda, MD). The oligonucleotide primers used for the amplification of the 18S ribosomal RNA were provided in a kit (Quantum RNA 18S Internal Standards; Ambion Inc., Austin, TX). Taq polymerase (Pharmacia-LKB) was selected for PCR amplification. Cycle parameters were the same for all primers used (denaturation 94°C, 30 seconds; annealing 60°C, 30 seconds; extension 72°C, 30 seconds) with an identical number of cycles (26, 28, 30, 32, 34 , and 36 cycles) for both sets of primers. The PCRamplified DNAs were fractionated on a 10% polyacrylamide gel and their position revealed by ethidium bromide staining. The gel photograph was scanned with an image analyzer (Visage 110S Bioimage; Millipore), to quantify the alterations in the amounts of both the ␣5 and 18S PCR-amplified fragments at the various cell densities selected.
Northern blot analyses were conducted on total RNA isolated from both subconfluent and 48-hour postconfluent RCECs as detailed earlier. Total RNA was size-fractionated on a 1.2% formaldehyde-agarose gel and blotted onto a membrane (Hybond-Nϩ; Amersham Canada, Oakville, Ontario, Canada), as described elsewhere. The membrane was then hybridized at 42°C in 50% (vol/vol) formamide 5ϫ SSPE (1ϫ SSPE is 0.15 M NaCl; 10 mM NaH 2 PO 4 ; 1 mM EDTA [pH 7.4]), 5ϫ Denhardt's solution (1ϫ Denhardt's solution is 0.02% polyvinylpyrrolidone, 0.02% single-density gradient [Ficoll] and 0.02% bovine serum albumin), 0.1% SDS, and sheared denatured salmon sperm DNA at 0.3 mg/mL. Blots were washed once at 25°C in 2ϫ SSC-0.1% SDS (1ϫ SSC is 150 mM NaCl and 15 mM sodium citrate), and twice at 42°C in 0.2ϫ SSC-0.1% SDS. The labeled probe used for hybridization consisted of an 800-bp EcoRI-EcoRI restriction fragment derived from the ␣4 cDNA. 49 Membranes were autoradiographed at Ϫ70°C for the indicated period.
SDS-PAGE and Western Blot
The protein concentration from postconfluent and subconfluent RCEC crude nuclear extracts was evaluated by the Bradford procedure and further validated after Coomassie blue staining of SDS-polyacrylamide fractionated nuclear proteins. Approximately 20 g of proteins was added to 1 volume of sample buffer (6 M urea, 63 mM Tris [pH 6.8], 10% [vol/vol] glycerol, 1% SDS, 0.00125% [wt/vol] bromophenol blue, 300 mM ␤-mercaptoethanol) and then size fractionated on a 10% SDS-polyacrylamide minigel before being transferred onto a nitrocellulose filter. A full set of protein molecular mass markers (InvitrogenGibco) was also loaded as a control to evaluate protein sizes. The blot was then washed once in TS buffer (150 mM NaCl, 10 mM Tris-HCl [pH 7.4]) and four times (5 minutes each at 22°C) in TSM buffer (TS buffer plus 5% [wt/vol] fat-free dried milk and 0.1% Tween 20). Then, a 1:500 dilution of a rabbit polyclonal antibody raised against the transcription factors Sp1 or Sp3 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), or a 1:10,000 dilution of a mouse monoclonal antibody (C-2-10 50 ) raised against the C-terminal end of the DNA binding domain of bovine poly(ADP-ribose) polymerase (PARP; kindly provided by Guy G. Poirier, Unit of Health and Environment, CHUL Research Center, Qué-bec, Canada), was added to the membrane-containing TSM buffer and incubation proceeded for 2 hours at 22°C. The blot was then washed in TSM buffer and incubated an additional 1 hour at 22°C in a 1:1000 dilution of a peroxidase-conjugated goat anti-mouse immunoglobulin G (Jackson ImmunoResearch Laboratory, West Grove, PA). The membrane was successively washed in TSM (four times, 5 minutes each) and TS (two times, 5 minutes each) buffers before immunoreactive complexes were revealed with Western blot chemiluminescence reagents (Renaissance; NEN Dupont, Boston, MA) and autoradiographed.
RESULTS
Effect of Cell Density on the ␣5 Promoter Function
Although expression of the ␣5 integrin subunit has been reported in the human corneal epithelium, 16 cultured cells are inappropriate as a model for conducting detailed gene promoter studies, primarily because of the difficulties encountered in both culturing and transfecting these cells in vitro. 52, 54 In contrast, RCECs are easy to maintain in culture without the need for feeder cells. Most of all, they can be transfected with high efficiency by a polycationic detergent used as a transfection reagent (Lipofectamine; InvitrogenGibco)-mediated gene transfer 31, 55, 56 which makes them an ideal cellular model to conduct gene promoter studies. As the proliferative state of a particular cell type changes with cell density, probably as a result of altered gene expression, we exploited semiquantitative RT-PCR analyses to investigate whether transcription of the ␣5 integrin subunit gene is under the influence of the cell density reached by primary cultured RCECs (Fig. 1) . PCR amplifications were performed on reversetranscribed total RNA obtained from both subconfluent and postconfluent RCECs. Coamplification of the 18S ribosomal RNA was also performed for normalization purposes. The specific ␣5 PCR product, which appeared as a single DNA fragment of the expected size (171 bp) under all culture conditions (subconfluent and postconfluent RCECs) was detectable on the gel after 30 cycles of amplification and remained linear up to 34 cycles (Fig. 1A) . However, a significant reduction was observed for the corresponding PCR amplification cycles in postconfluent cells. Normalization of the ␣5 signal to that of the 18S rRNA, which appear as a single band of the appropriate size (489 bp) in subconfluent RCECs but as a doublet in postconfluent cells (probably as a result of alternative splicing events occurring at high cell density), provided evidence that the amount of ␣5 transcript is on average 4.6 Ϯ 0.3 times lower in postconfluent RCECs than in subconfluent cells (as revealed through densitometric analyses of the amplified PCR products). As a control, we also examined whether the expression of a class II gene, the transcription of which is not regulated by Sp1, remains unaltered by the state of cell density. For this purpose, we selected the gene encoding the human ␣4 integrin subunit, the expression of which has been found only in a restricted number of tissues, including the cornea, 16 both lymphoid and myeloid cells, 57 and differentiating skeletal muscle. 58 We have reported the binding of transcription factors to the ␣4 basal promoter, 56 of which none belong to the Sp1 family. Besides, no GC-rich Sp1 target sites are found in the sequence of the ␣4 promoter. 49 The selection of this gene also relies on the fact that cotransfection of the ␣4 promoter along with either the Sp1 or Sp3 expression plasmids (pPACSp1 and pPACSp3) in Sp1-deficient Drosophila Schneider cells had no influence at all on the transcriptional activity directed by the ␣4 promoter (data not shown). As revealed on Figure 1B (left), PCR amplification yielded the expected 772-bp ␣4 fragment. However, no alteration was observed in the amount of ␣4 amplification product between reverse-transcribed mRNAs prepared from postconfluent and subconfluent cells on normalization to the 28S ribosomal RNA. We next isolated total RNA from either postconfluent or subconfluent RCECs and examined the ␣4 transcript by Northern blot analysis. After only a few hours of exposure, a single mRNA species of approximately 6.5 kb corresponding to the previously reported major ␣4 transcript 49 was observed just above the 28S rRNA (Fig. 1B, right) . As expected, expression of the ␣4 transcript was not altered when RNA was isolated from postconfluent RCECs. We therefore conclude that the relative concentration of the ␣5 mRNA, but not that of the ␣4 transcript, is considerably reduced when RCECs reach confluence. Regulation of the ␣5 Gene Promoter by Sp1/Sp3 3745
To determine whether the cell-density-dependent alterations observed in the amount of ␣5 mRNA also translate into similar alterations in the activity directed by the ␣5 gene promoter, transfection analyses were conducted in RCECs. Because the upstream regulatory sequences from the rabbit ␣5 integrin subunit gene have not been cloned yet, we selected the human ␣5 gene to conduct the following experiments, because recombinant constructs bearing the CAT reporter gene under the control of various lengths from the human ␣5 gene promoter were already available. 37 These constructs were therefore transiently transfected into either postconfluent or subconfluent RCECs (Fig. 2) . Consistent with a previously published study, 37 most of the basal ␣5 promoter activity was found to be determined by the ␣5 sequences extending up to position Ϫ132 (in plasmid Ϫ132␣5CAT), the shorter ␣5 promoter-bearing construct (in this case, Ϫ42␣5CAT) being 22 times less active than the former when RCECs were cultured to subconfluence (Fig. 2B) . Extending further up to ␣5 position Ϫ178 or Ϫ954 did not increase further but rather resulted in a weak reduction (with the Ϫ954␣5CAT plasmid) in ␣5 promoter activity. Consistent with the near fivefold reduction in the amount of ␣5 transcript observed when RCECs reach confluence, transfection of postconfluent RCECs with the ␣5/ CAT plasmids also resulted in a 9-to 13-fold reduction in the ␣5 promoter activity when compared with the activity measured in subconfluent cells (Fig. 2B) . We therefore conclude that the transcriptional activity directed by the promoter of the ␣5 gene is dramatically affected by the extent of cell density reached by RCECs in vitro.
Binding of Nuclear Proteins to the ␣5 Promoter
To determine whether the changes in the activity directed by the ␣5 promoter result from altered binding of nuclear regulatory proteins to the ␣5 regulatory elements in postconfluent versus subconfluent RCECs, differential EMSA experiments were conducted. For this purpose, we focused our attention on the Ϫ92 to Ϫ132 DNA segment from the ␣5 promoter, because it was shown to be required to reach maximum ␣5 promoter activity after transfection into RCECs (Fig. 2B) . In the present study, deletion of this region from the ␣5 promoter yielded a drastic 18-and 13-fold reduction of CAT gene activity after transfection of either postconfluent or subconfluent RCECs, respectively (Fig. 2B) . We therefore synthesized a dou- ble-stranded oligonucleotide bearing the GC-rich Ϫ132 to Ϫ92 region from the ␣5 promoter (designated ␣5.1) and used it as a labeled probe in EMSAs. Incubation of the ␣5.1-labeled probe with nuclear proteins from RCECs revealed the formation of two, low electrophoretic mobility DNA-protein complexes (denoted R1 and R2) when nuclear proteins from subconfluent, but not from postconfluent, cells were used in the assay (Fig. 3A, left) . In contrast, a fast-migrating complex (designated C1) was yielded by the extract from postconfluent, but not by that from subconfluent, RCECs. Considering the high content of GC residues in the Ϫ132/Ϫ92 ␣5 promoter and the fact that this sequence bears multiple putative binding sites for the transcription factors that belong to the Sp1 family, competition experiments in EMSAs were then performed. As shown on Figure 3A (right), both unlabeled ␣5.1 and an oligonucleotide bearing the high-affinity target site for Sp1 could compete for the formation of the R1 and R2 complexes. As expected, the high-affinity target site for the unrelated NF1 protein did not compete for the formation of both of these complexes. Recently, we reported the binding of Sp1 to a GA-rich target site that is part of a regulatory element from the ␣5 promoter located between positions Ϫ82 and Ϫ56 (and designated FRE) that confer responsiveness to Fn. 31 As with both the Sp1 and ␣5.1 oligonucleotides, an oligomer bearing the sequence from the ␣5 FRE competed for the formation of both R1 and R2 (Fig.  3A, right) . The use of shorter derivatives of the ␣5.1 oligonucleotide that extend from position Ϫ143 to Ϫ106 (␣5.2) and Ϫ105 to Ϫ86 (␣5.3) did not alter significantly the formation of both the R1 and R2 complexes, therefore suggesting that the proteins yielding R1 and R2 probably recognize a target site that overlaps the Ϫ106/Ϫ105 junction of these oligonucleotides. A similar competition experiment was conducted on the C1 complex detected when crude nuclear proteins from postconfluent RCECs were used in the EMSA. To improve separation of the complexes that constitute the C1 complex, the concentration of the native polyacrylamide gel was reduced to 5%. As shown on Figure 3B , C1 is made up of two closely migrating DNA-protein complexes that we designated C1a and C1b. Formation of both complexes was abolished by the unlabeled Sp1 and ␣5.1 oligonucleotides but not by the unrelated NF1 oligomer, suggesting that the proteins yielding C1a and C1b must be closely related to Sp1.
As further evidence that members of the Sp1 family bind the Ϫ132/Ϫ92 sequence of the ␣5 promoter, supershift experiments in EMSA were conducted. As shown in Figure 3C , formation of the R1 complex, but not that of R2, was totally prevented by the addition of an antibody directed against Sp1. A supershifted complex with very low electrophoretic mobility (SSC) also appeared on the gel on incubation with the Sp1 Ab. That the supershifted complex is located at the top of the gel is not uncommon 31 and results from the shorter time of migration that is necessary to visualize properly the position of the free probe. Similarly, formation of R2 (and to some extent that of R1) was efficiently prevented by the addition of an antibody directed against Sp3. Taken together, these results suggest that complex R1 contains both Sp1 and Sp3 and that complex R2 results solely from the recognition of the ␣5.1-labeled probe by Sp3. Indeed, the addition of both the Sp1 and Sp3 Abs to the reaction mix totally prevented formation of both complexes R1 and R2, as expected (Fig. 3C) . That both Sp1 and Sp3 yield DNA-protein complexes that comigrate in EMSA is not unique and has been reported in many studies.
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The results presented in Figure 3A suggest that dramatic alterations in either the concentration or the DNA binding affinity of both Sp1 and Sp3 for their Ϫ132/Ϫ92 target site 
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Regulation of the ␣5 Gene Promoter by Sp1/Sp3 3747 occur in RCECs grown to different cell densities. To determine which of these two hypotheses account for the alterations in the formation of both Sp1/Sp3 complexes R1 and R2, Western blot analyses were conducted on the nuclear extracts used in Figure 3A . As revealed in Figure 4 , the pattern of Sp1/Sp3 protein expressed by both subconfluent and postconfluent RCECs perfectly matched that observed in the EMSA, the maximum Sp1/Sp3 expression being observed at subconfluence, whereas both proteins totally disappeared when cells were maintained at postconfluence for 48 hours. Much shorter protein derivatives that were recognized by both the Sp1 and Sp3 mAbs were observed in the same extracts that also support formation of the C1 complex (estimated molecular mass of 40 to 45 kDa with the Sp1 mAb and under 40 kDa with the Sp3 mAb). It is worth pointing out that the Sp1 mAb recognized a doublet of closely migrating proteins in the crude extract from 48-hour postconfluent RCECs that closely resemble that yielded by the C1a and C1b complexes in EMSA (Fig. 3B) . To eliminate the possibility that extinction of Sp1/Sp3 may have resulted from their proteolytic cleavage by apoptotic caspases as a consequence of the postconfluent RCECs' progressing into apoptosis, blotted proteins were probed with a monoclonal antibody (C-2-10) raised against the bovine PARP protein 50 whose cleavage by caspase 3 is well recognized as an early marker of apoptosis. 62 The epitope recognized by the C-2-10 antibody is localized near the C-terminal end of the PARP DNA binding domain, a region shown to be totally conserved between murine, bovine, and human PARP. 50 Cleavage of the 113-kDa mature PARP by caspase-3 yields two degradation products with molecular masses of 89 and 24 kDa, of which the larger, which bear the intact epitope, can be recognized efficiently by the C-2-10 mAb. 63 As shown on Figure 4 , a single clear signal corresponding to the 113-kDa mature PARP protein was observed with the protein preparation from both subconfluent and 48-hour postconfluent RCECs. Crude nuclear proteins from HL60 cells exposed or not to the cell death inducer VP16 (and kindly provided by Guy G. Poirier) were also included as the control. The 89-kDa PARP caspase-3 cleavage product, which was easily detectable in the extract from apoptotic VP16-treated HL60 cells, was not detectable in postconfluent RCECs (as well as in subconfluent cells), clear evidence that postconfluent cells are not committed to apoptosis.
As a next step, we wanted to determine whether disappearance of both Sp1 and Sp3 at postconfluence indeed results from their proteolytic degradation through the action of proteases expressed in postconfluent RCECs but missing in subconfluent cells. Crude nuclear proteins prepared from pituitary GH4C1 cells, which express high levels of Sp1/Sp3, were used as a source of exogenous Sp1/Sp3 proteins in these experiments. A constant amount from the GH4C1 extract (5 g) was then incubated with increasing concentrations (1-10 g) of nuclear proteins obtained either from postconfluent (C) or subconfluent (SC) RCECs and incubated for 90 minutes at 37°C before the addition of the Sp1-labeled probe and further analysis through EMSA. As shown in Figure 5A , incubation in the presence of the extract from subconfluent RCECs had no influence on the formation of the Sp1/Sp3 complexes normally yielded by the GH4C1 extract. In contrast, the addition of increasing amounts of extracts from confluent RCECs resulted in a complete disappearance of both transcription factors. The formation of intermediate, fast-migrating complexes that are thought to result from the proteolytic degradation of these proteins by unknown proteases (as their formation is inhibited by the unlabeled Sp1 oligonucleotide; data not shown) was also observed when the extract from postconfluent RCECs was added (Fig. 5A) . A similar experiment was repeated by varying the time of incubation, rather than the protein concentration, during the assay. The Sp1/Sp3-containing extract from GH4C1 cells (5 g) was therefore incubated with a constant amount of nuclear proteins (5 g) from both subconfluent and postconfluent RCECs and incubated for various periods of time (0 -120 minutes) at 37°C before the addition of the Sp1-labeled probe and further analysis through EMSA. As shown on Figure 5B , an incubation of 120 minutes at 37°C was necessary to obtain a substantial reduction (but no total disappearance) in the formation of the Sp1/Sp3 complexes in EMSA. Only 30 minutes were required, however, when the extract from confluent cells was used, with no detectable Sp1/Sp3 signals present after 60 minutes of incubation. We therefore conclude that the lack of formation for both complexes R1 and R2 when nuclear extracts from postconfluent RCECs are used in EMSA can be accounted for by the corresponding lack of expression of both Sp1 and Sp3 in these cells and not by alterations in the affinity of these proteins for their target sequences. Disappearance of Sp1 and Sp3 at a high cell density appears to be the consequence of their proteolytic degradation by an unknown pro- tease that is highly active (or expressed) only in postconfluent RCECs. Such degradation of Sp1/Sp3 is a progressive event, because cleavage intermediates are clearly detectable when crude nuclear protein preparations obtained from RCECs cultured at 100% confluence for 0 and 1 days are used as the source of protein for the Western blot analysis (data not shown).
Regulatory Influence of Sp1/Sp3 on the ␣5 Promoter
To determine the precise position of the Sp1 target sites within the Ϫ82/Ϫ56 ␣5 FRE and the Ϫ92/Ϫ132 ␣5 promoter segment, DNaseI footprinting experiments were conducted with a labeled probe that covers the entire basal promoter area. As shown in Figure 6A (and also summarized in Fig. 6B) , purified Sp1 protected a region from the ␣5 FRE located between positions Ϫ50 and Ϫ71, which we designated the proximal Sp1 site (Sp1p). In addition, a weaker, partial protection was observed between positions Ϫ101 and Ϫ117. This other site, which we designated the distal Sp1 site (Sp1d), overlaps the junction between the ␣5.2 and ␣5.3 oligonucleotides (Fig. 6B ) that have been used as unlabeled competitors in the EMSA experiment shown in Figure 3A , which also explains why neither could compete efficiently for the formation of the R1 and R2 Sp1/Sp3 DNA-protein complexes. Both the proximal and distal Sp1 sites from the recombinant plasmid Ϫ132␣5CAT were mutated either individually or in combination, using site-directed mutagenesis to assess precisely the regulatory influence of each site on the transcriptional activity directed by the ␣5 promoter. The wild-type Ϫ132␣5CAT plasmid as well as its mutated derivatives were transfected into either subconfluent or 48-hour postconfluent RCECs. At subconfluence, mutation of the proximal Sp1 site (in plasmid Ϫ132␣5Mp) resulted in a fivefold reduction in the activity normally directed by the ␣5 promoter, whereas the distal Sp1 site had little influence on the activity directed by the Ϫ132␣5CAT when mutated alone (in plasmid Ϫ132␣5Md; Fig. 6C ). However, mutating both the proximal and the distal sites together (in plasmid Ϫ132␣5Mdϩp) resulted in a reduction in ␣5 promoter function nearly twice that seen with the Ϫ132␣5Mp construct (eightfold reduction) therefore providing evidence that the distal Sp1 site indeed contributes, although to a lesser level than the proximal site, to basal ␣5 promoter function. When transfected in 48-hour postconfluent RCECs, mutation of the proximal Sp1 site yielded only a moderate (2.6-fold) reduction in the ␣5 promoter activity and unlike in subconfluent cells, no further reduction occurred when the distal Sp1 site was also mutated (2.5-fold reduction at postconfluence versus eightfold reduction in subconfluent RCECs). We therefore conclude that two distinct Sp1 target sites from the ␣5 promoter, a proximal and a distal one, are bound in vitro by Sp1 and that the positive regulatory influence they mediate is under the influence of the cell density reached by primary cultured RCECs.
To evaluate the respective contribution of both Sp1 and Sp3 on the activity directed by the ␣5 promoter, cotransfection experiments were conducted into Drosophila SL2 Schneider cells. These cells are known to be deficient in producing these transcription factors, which make them an ideal system for studying gene expression or transcription factors function (for a review, see Ref. 64) . The plasmids Ϫ132␣5CAT, Ϫ92␣5CAT, and Ϫ42␣5CAT were cotransfected into Schneider cells, either alone or with recombinant plasmids (pPacSp1 and pPacSp3) containing either the Sp1 or Sp3 cDNA under the control of the Drosophila actin gene promoter and therefore ensuring high levels of both these proteins in Schneider cells. As shown in Figure 7 , none of these three recombinant plasmids could RCECs and incubated in buffer D for 90 minutes at 37°C before the addition of a 5Ј end-labeled oligonucleotide bearing the high-affinity binding site for Sp1. Formation of the Sp1 and Sp3 DNA-protein complexes was then examined by EMSA, as in Figure 3. (B) Approximately 5 g from the GH4C1 Sp1/Sp3-containing extract was incubated with 5 g nuclear proteins from both subconfluent and postconfluent RCECs and incubated for various times (0 -120 minutes) at 37°C before the addition of the Sp1-labeled probe. Formation of the Sp1 and Sp3 DNA-protein complexes was then examined by EMSA, as in (A). U, unbound fraction of the labeled probe; P, labeled probe alone.
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Regulation of the ␣5 Gene Promoter by Sp1/Sp3 3749 determine high basal promoter activity when transfected alone in Schneider cells. Cotransfection of either the Sp1 or Sp3 expression plasmids (or the combination of both) did not have any influence at all on the CAT activity directed by the Ϫ42␣5CAT plasmid, providing evidence that the 42 bp upstream from the ␣5 mRNA start site are insufficient to direct transcription in vitro (Fig. 7) . Extending further the ␣5 promoter up to position Ϫ92 yielded 20-and 6.5-fold increases in CAT activity on cotransfection with the Sp1 and Sp3 expression plasmids, respectively. Cotransfection of pPacSp1 with the Ϫ132␣5CAT recombinant plasmid increased CAT activity by fivefold over the level directed by the plasmid Ϫ92␣5CAT (Fig. 7) . These results provide evidence that the Ϫ132/Ϫ92 ␣5 promoter segment contribute to the Sp1-mediated positive regulatory influence directed by this promoter in vitro, although to a lesser level than that directed by the Ϫ42/Ϫ92 segment (which yielded a near 20-fold increase with Sp1 by comparison to the fivefold increase mediated by the Ϫ92/ Ϫ132 segment). The findings are also consistent with the results obtained after transfection of both the wild-type and mutated constructs into RCECs (Figs. 2B, 6C) . Cotransfection of the Ϫ132␣5CAT with pPacSp3 did not yield promoter activation significantly greater than that obtained with the Ϫ92␣5CAT plasmid (8-and 6.5-fold activation, respectively). Unlike results reported in other studies, [65] [66] [67] no synergistic nor antagonistic influence resulted from the cotransfection of both pPacSp1 and pPacSp3 along with any of these ␣5CAT recombinant plasmids (Fig. 7) . We therefore conclude that Sp1 exerts its synergistic positive influence on the activity directed by the ␣5 promoter through the recognition of both its proximal and distal target sites. In contrast, Sp3 appears to exert its 6.5-to 8-fold positive influence through the recognition of a single regulatory element located on the 50-bp Ϫ42/Ϫ92 DNA segment (most likely through the proximal site also recognized by Sp1).
Because postconfluent RCECs do not express Sp1/Sp3 proteins with the appropriate molecular mass, we examined whether restoring expression of Sp1 into Sp1-deficient postconfluent RCECs would alter the activity normally directed by the ␣5 promoter. Both the Ϫ92␣5CAT and Ϫ132␣5CAT plas- Figure 8 , cotransfection of pSiSp1 had no influence on the CAT activity directed by either ␣5CAT plasmids in subconfluent RCECs. This result was anticipated, because subconfluent RCECs already express substantial amounts of endogenous Sp1, therefore suggesting that both ␣5 promoter constructs are already under the positive influence of Sp1, and no further increase in activity can be reached, despite the forced expression of Sp1 encoded by pSiSp1. However, performing the same experiment in Sp1-deficient postconfluent RCECs resulted in a modest but statistically significant 2.3-and 2.6-fold increase in the promoter activity directed by the plasmids Ϫ92␣5CAT and Ϫ132␣5CAT, respectively.
DISCUSSION
Although expression of the ␣5 integrin subunit has been unquestionably recognized in the corneal epithelium, the way by which its gene is regulated during the process of corneal wound healing remains obscure. The present study was undertaken to shed light on the variations that may exist in the level of expression of this gene during corneal wounding by exploiting both postconfluent and subconfluent cultures of RCECs as a model to study ␣5 gene promoter function in vitro. The results shown in the present study demonstrated clearly that efficient transcription of the ␣5 gene, but not that of the ␣4 gene (the expression of which is apparently not under the influence of Sp1/Sp3), is dependent on the recognition of two target sites (a proximal and a distal site) from the ␣5 basal promoter by transcription factors that belong to the Sp1 family. We demonstrated that the activity directed by the ␣5 promoter is substantially abrogated when RCECs reach confluence (as revealed by both RT-PCR analyses and transfection of the CAT/␣5 promoter recombinant constructs). The strong reduction in the activity of the ␣5 promoter when RCECs reach a high cell density appears to be the consequence of a reduced expression of Sp1/Sp3 that apparently results from their proteolytic cleavage by yet unknown proteases. Considering the ubiquitous nature of the expression of the ␣5 integrin subunit, it is no surprise that transcription of its gene would turn out to be dependent also on the positive influence of ubiquitously expressed transcription factors. The results presented herein demonstrate clearly the critical function played by Sp1, and to some extent also Sp3, in the activity directed by the ␣5 promoter. We directed our attention primarily toward Sp1 and Sp3, and not Sp2, Sp4, and Sp5 for the following reasons: (1) Sp4 was expressed at only very low levels in primary cultures of both human 68 and rabbit (data not shown) corneal epithelial cells, as revealed by Western blot analyses, and was not shown to bind GC-rich target sites in supershift experiments; (2) Sp2 was not reported to recognize the classic GC box that is bound by the remaining members of this family, but rather targets GT-rich elements; and (3) Sp5 is tissue-specifically expressed only during early development. 36, 69 Besides, Sp5 bears only one Sp1-like zinc finger and apart from this Zn finger, it has little similarity to any other member of the Sp1 family. Results from Drosophila cell transfections provided evidence that Sp3 must exert its regulatory influence through the recognition of a target site located on the Ϫ42/Ϫ92 ␣5 promoter segment because extending further the length of the ␣5 promoter to position Ϫ132 did not increase further its positive influence. Sp1, however, appeared to act synergistically on the activity directed by the ␣5 promoter, because extending the ␣5 basal promoter, which already bears a strong Sp1 site, from position Ϫ92 to position Ϫ132 resulted in a further increase in the ␣5 promoter's strength. Synergistically acting Sp1 target sites are not uncommon, because they have been identified in the promoter of many genes 29, 30, 70 including the gene for PARP. 71 We recently provided evidence that Sp1 interacts with a GA-rich target site from the ␣5 promoter, located between positions Ϫ82 and Ϫ56 (the FRE element), which also confers responsiveness to the ␣5␤1 ligand Fn. 31 This positive regulatory influence of Sp1 on the ␣5 promoter was shown to be mediated by its interaction with two target sites, a proximal site located from positions Ϫ50 to Ϫ71, and a distal site, located from positions Ϫ101 to Ϫ117. Although the proximal Sp1 site was clearly the most important, both the proximal and distal sites are necessary to reach maximum activation in Drosophila SL2 cells. That mutating the distal Sp1 site had little influence on the ␣5 promoter activity (Fig. 6) whereas deletion of the Ϫ132 to Ϫ92 ␣5 promoter segment resulted in a dramatic reduction in the basal promoter activity (Fig. 2) can be explained by the presence of target sites for transcription factors other than Sp1 that substantially contribute to the influence of the Ϫ92/Ϫ132 upstream sequence in primary cultured RCECs. Although target sites for nuclear transcription factors other than Sp1 have been identified in the ␣5 promoter downstream of position Ϫ92, including sites for both AP-1 and C/EBP, 72 no such protein has been reported to bind the Ϫ92/Ϫ132 ␣5 promoter segment.
Sp3 also binds GC-or GA-rich target sites and is therefore likely to bind the GA-rich Sp1 binding site (Sp1p) identified in the ␣5 FRE. The lack of synergy between Sp1 and Sp3 when both expression plasmids are transfected in Schneider cells support this hypothesis. Both must therefore compete with one another for binding their respective target site. The fact that the transactivation properties of Sp1 remained unaltered, even in the presence of Sp3, also suggests that binding of Sp1 predominates over that of Sp3 for the FRE GA-rich target site.
It is noteworthy that 48-hour postconfluent RCECs, unlike subconfluent cells, lose expression of the typical Sp1 and Sp3 proteins. This is somehow consistent with the results published by Chen et al., 73 who reported a substantial reduction, but no complete disappearance, of Sp1 in 5-day postconfluent RCECs. A cell-density-mediated upregulation in the amount of Sp1 has also been reported to occur in primary cultures of human corneal stromal cells. 74 However, the immunohistochemical staining conducted by these investigators clearly indicated that the cells plated at the highest cell density selected (1.25 ϫ 10 6 cells/cm 2 for 18 hours) barely reached 75% confluence, a condition we consider to be subconfluent and under which Sp1 is also highly expressed.
The disappearance of full-length Sp1 and Sp3 in 48-hour postconfluent RCECs combined with the presence of much shorter protein versions that are immunologically recognized by both the Sp1 and Sp3 mAbs and the fact that the nuclear extract from postconfluent RCECs possess the ability to degrade Sp1 from a foreign source (for instance that from GH4C1 cells) points toward the possibility that both proteins are subjected to proteolysis when RCECs reaches a high cell density. This hypothesis is supported by the fact that unlike the DNAbinding activity of Sp1, which has been reported to drop considerably during the course of corneal epithelial cell differentiation, no corresponding alteration in the steady state level of Sp1 mRNA occurs. 73 Cleavage of Sp1 by caspases has recently been shown to occur as a consequence of cells involved in the process of apoptosis. 75, 76 Indeed, caspase 3, and the caspase 3-activated downstream caspases 6 and 7, have been shown to cleave Sp1 into three distinctive products of 68, 45, and 22 kDa. It is interesting to point out that the smaller Sp1 cleavage product cannot be detected immunologically through Western blot, because it lacks the epitope recognized by the Sp1 antibody, and has been postulated to function as a dominant negative Sp1 derivative, since it may still bind DNA but no longer possesses the ability to activate transcription. 75 However, we clearly demonstrated that postconfluent RCECs were not committed to apoptosis, because no cleavage of mature PARP by caspase 3, which is considered an early event of apoptosis, occurs in postconfluent RCECs. Besides, although the size of the Sp1 cleavage product detected in postconfluent RCECs (40 -45 kDa) may match that of the Sp1 apoptotic fragment of 45 kDa, no fragment with a molecular mass of 68 kDa has ever been observed in RCECs under these or any other culture conditions. We therefore postulate that once RCECs reach postconfluence, they either activate or start producing one protease (or a few) for which one of the immediate downstream target proteins is Sp1. Inactivating Sp1 and Sp3 through their degradation by one or a few proteases that would either be activated or expressed once the cells reach confluence would also explain why we could not fully restore levels of CAT activity similar to that observed in subconfluent RCECs when postconfluent cells were forced to express Sp1 from the plasmid SpSp1 (Fig. 8) . Under such a cell culture condition, it is likely that a large proportion of the de novo synthesized Sp1 is inactivated in the same way as endogenous Sp1.
Cleavage of Sp1 by one or more cysteine proteases as cells progress through differentiation has been reported before. In one such study, differentiation of embryonal carcinoma cells into parietal ectoderm-like cells was accompanied by a decrease in nuclear levels of Sp1 as a consequence of its cleavage by cysteine-like nuclear protease activity. 77 Although transcription factors other than Sp1 (ATF-1, NF-YA, NF-YB, and the octamer-binding proteins Oct-1 and Oct-3) also have been shown to be targets of this cysteine protease, they possess a very restricted activity because these nuclear proteins were the only recognized substrates of this enzyme. Such results would support the idea that antiproliferative effects or cell differentiation somehow increases nuclear protease activity and decreases the level of specific transcription factors including Sp1. One must also consider, however, that increasing stimulation of one or a few signal transduction pathways through cell-cell contacts as cells are reaching confluence may activate early cleavage of Sp1/Sp3 and therefore preclude the growth arrest that is typical of postconfluent cells. Considering the high number of genes with transcription regulated by Sp1/Sp3, this would clearly represent a remarkable means for arresting cell growth and preventing cell proliferation after wound healing, especially considering the critical role Sp1 plays during the cell cycle. 79, 80 Indeed, Sp1 has been shown to interact directly with many nuclear proteins, including some, such as cyclin D1, the retinoblastoma protein (Rb), and the Rb-related proteins p107, E2F, p53, and mdm2, which play critical functions during the cell cycle. 79, [81] [82] [83] [84] [85] [86] [87] Most of all, Sp1 expression has been shown to predominate during the G 1 phase of the cell cycle and is then subjected to proteasome-dependent degradation before the S phase, a process that is thought to be dependent on the level of Sp1 phosphorylation. 88 However, these studies have been conducted in transformed culture cells and their relevance to primary cultured, untransformed cells remains unknown.
